Profil
Reid P.
Bissonnette currently works at Xenetic Biosciences, Inc., as Head-Translational Research & Development.
Dr. Bissonnette also formerly worked at Ligand Pharmaceuticals, Inc., as Associate Director, Huyabio International LLC, as Vice President-Pharmacology, Targazyme, Inc., as Vice President-Immuno-Oncology, and Arrivent BioPharma, Inc., as Head-Non-Clinical Research.
Dr. Bissonnette received his undergraduate degree and doctorate degree from McGill University.
Postes actifs de Reid Bissonnette
| Sociétés | Poste | Début |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Reid Bissonnette
| Sociétés | Poste | Fin |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Corporate Officer/Principal | - |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | - |
| ARRIVENT BIOPHARMA, INC. | Corporate Officer/Principal | - |
Formation de Reid Bissonnette
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Ligand Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Health Technology |
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
















